Cargando…

Bevacizumab and gefitinib enhanced whole-brain radiation therapy for brain metastases due to non-small-cell lung cancer

Non-small-cell lung cancer (NSCLC) patients who experience brain metastases are usually associated with poor prognostic outcomes. This retrospective study proposed to assess whether bevacizumab or gefitinib can be used to improve the effectiveness of whole brain radiotherapy (WBRT) in managing patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, R.F., Yu, B., Zhang, R.Q., Wang, X.H., Li, C., Wang, P., Zhang, Y., Han, B., Gao, X.X., Zhang, L., Jiang, Z.M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Associação Brasileira de Divulgação Científica 2017
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685055/ https://www.ncbi.nlm.nih.gov/pubmed/29185589 http://dx.doi.org/10.1590/1414-431X20176073

Ejemplares similares

Blood-brain barrier permeability of gefitinib in patients with brain metastases from non-small-cell lung cancer before and during whole brain radiation therapy
por: Zeng, Yin-duo, et al.
Publicado: (2015)

The role of whole brain radiation therapy in the management of melanoma brain metastases
por: Dyer, Michael A, et al.
Publicado: (2014)

Combining Whole-Brain Radiotherapy with Gefitinib/Erlotinib for Brain Metastases from Non-Small-Cell Lung Cancer: A Meta-Analysis
por: Zheng, Mao-hua, et al.
Publicado: (2016)

Whole-brain radiation therapy for brain metastases: detrimental or beneficial?
por: Gemici, Cengiz, et al.
Publicado: (2015)

Low-Dosage Bevacizumab Treatment: Effect on Radiation Necrosis After Gamma Knife Radiosurgery for Brain Metastases
por: Weng, Yuxiang, et al.
Publicado: (2021)

Comparison of whole brain radiation therapy for synchronous brain metastases with irradiation protecting the hippocampus versus whole brain radiotherapy for sequential brain metastases to boost irradiation in the treatment of brain metastases from SCLC: study protocol for a randomized controlled trial
por: Zhang, Xiaofang, et al.
Publicado: (2022)

Variations in whole brain radiation therapy fractionation for brain metastases in Victoria
por: Chee, Lessandra Yan Shan, et al.
Publicado: (2022)

High quality of 58-month life in lung cancer patient with brain metastases sequentially treated with gefitinib and osimertinib
por: Zhang, Ying, et al.
Publicado: (2021)

A phase III trial of topotecan and whole brain radiation therapy for patients with CNS-metastases due to lung cancer
por: Neuhaus, T, et al.
Publicado: (2009)

Evaluation on efficacy and safety of the addition of X-knife therapy to gefitinib in NSCLC patients with symptomatic brain metastases
por: Cai, Linbo, et al.
Publicado: (2016)

MLTI-06. BEVACIZUMAB VERSUS SURGICAL INTERVENTION FOR RADIATION NECROSIS IN PREVIOUSLY IRRADIATED BRAIN METASTASES
por: Hong, Christopher, et al.
Publicado: (2019)

Changes in cardiac aldosterone and its synthase in rats with chronic heart failure: an intervention study of long-term treatment with recombinant human brain natriuretic peptide
por: Zhu, X.Q., et al.
Publicado: (2014)

Shifting paradigms: whole brain radiation therapy versus stereotactic radiosurgery for brain metastases
por: Shinde, Ashwin, et al.
Publicado: (2019)

Integration of stereotactic radiosurgery or whole brain radiation therapy with immunotherapy for treatment of brain metastases
por: Su, Zhou, et al.
Publicado: (2020)

Bevacizumab reduces peritumoral brain edema in lung cancer brain metastases after radiotherapy
por: Hua, Yi‐Chun, et al.
Publicado: (2023)

Quality-of-life benefits and evidence of antitumour activity for patients with brain metastases treated with gefitinib
por: Katz, A, et al.
Publicado: (2003)

Estimating prognosis at the time of repeat whole brain radiation therapy for multiple brain metastases: The reirradiation score
por: Logie, Natalie, et al.
Publicado: (2017)

BEVACIZUMAB FOR SYMPTOMATIC RADIATION NECROSIS IN BRAIN METASTASES: OUTCOMES FROM A SINGLE-CENTER RETROSPECTIVE ANALYSIS
por: Roberto, Katrina, et al.
Publicado: (2023)

Whole brain radiotherapy with radiosensitizer for brain metastases
por: Viani, Gustavo Arruda, et al.
Publicado: (2009)

Additional radiation boost to whole brain radiation therapy may improve the survival of patients with brain metastases in small cell lung cancer
por: Sun, Han, et al.
Publicado: (2018)

Using combined Lactobacillus and quorum quenching enzyme supplementation as an antibiotic alternative to improve broiler growth performance, antioxidative status, immune response, and gut microbiota
por: Sun, X.X., et al.
Publicado: (2022)

Exploration of the recurrence in radiation brain necrosis after bevacizumab discontinuation
por: Zhuang, Hongqing, et al.
Publicado: (2016)

Gefitinib Plus Chemotherapy vs Gefitinib Alone in Untreated EGFR-Mutant Non–Small Cell Lung Cancer in Patients With Brain Metastases: The GAP BRAIN Open-Label, Randomized, Multicenter, Phase 3 Study
por: Hou, Xue, et al.
Publicado: (2023)

Enhanced Phosphorylation of Bax and Its Translocation into Mitochondria in the Brains of Individuals Affiliated with Alzheimer’s Disease
por: Henderson, L.E., et al.
Publicado: (2017)

Comparison of proton therapy techniques for treatment of the whole brain as a component of craniospinal radiation
por: Dinh, Jeffrey, et al.
Publicado: (2013)

Clinical features of brain metastases in breast cancer: an implication for hippocampal-sparing whole-brain radiation therapy
por: Wu, San-Gang, et al.
Publicado: (2016)

Bevacizumab and risk of intracranial hemorrhage in patients with brain metastases: a meta-analysis
por: Yang, Lin, et al.
Publicado: (2017)

Self-Healing Supramolecular Hydrogels Based on Reversible Physical Interactions
por: Strandman, Satu, et al.
Publicado: (2016)

Clinical Features of Brain Metastases in Small Cell Lung Cancer: an Implication for Hippocampal Sparing Whole Brain Radiation Therapy()
por: Guo, Wen-Long, et al.
Publicado: (2016)

Phase II trial of carboplatin and bevacizumab in patients with breast cancer brain metastases
por: Leone, Jose Pablo, et al.
Publicado: (2020)

Delivery of the Sox9 gene promotes chondrogenic differentiation of human umbilical cord blood-derived mesenchymal stem cells in an in vitro model
por: Wang, Z.H., et al.
Publicado: (2014)

A phase III randomised controlled trial of erlotinib vs gefitinib in advanced non-small cell lung cancer with EGFR mutations
por: Yang, J J, et al.
Publicado: (2017)

Upfront whole brain radiotherapy for multiple brain metastases in patients with EGFR-mutant lung adenocarcinoma
por: Li, Changhui, et al.
Publicado: (2019)

Imaging zebrafish neural circuitry from whole brain to synapse
por: Leung, Louis C., et al.
Publicado: (2013)

Bevacizumab for the treatment of non-small cell lung cancer patients with synchronous brain metastases
por: Ascha, Mustafa S., et al.
Publicado: (2019)

The benefit of whole brain reirradiation in patients with multiple brain metastases
por: Ozgen, Zerrin, et al.
Publicado: (2013)

Fractionated stereotactic radiation therapy for intact brain metastases
por: Marcrom, Samuel R., et al.
Publicado: (2017)

Yeast CUP1 protects HeLa cells against copper-induced stress
por: Xie, X.X., et al.
Publicado: (2015)

Bevacizumab-based treatment as salvage therapy in patients with recurrent symptomatic brain metastases
por: Berghoff, Anna Sophie, et al.
Publicado: (2020)

Bevacizumab treatment for radiation brain necrosis: mechanism, efficacy and issues
por: Zhuang, Hongqing, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_i0s3a0pjh52opahc0vosu7u2tr